5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
about
A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism.Functional role of Calstabin2 in age-related cardiac alterations.Mechanotransduction in cardiac hypertrophy and failure.Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis.Four and a Half LIM Domains 1b (Fhl1b) Is Essential for Regulating the Liver versus Pancreas Fate Decision and for β-Cell RegenerationHaploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.Molecular profiling of dilated cardiomyopathy that progresses to heart failure.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Cardiovascular homeostasis dependence on MICU2, a regulatory subunit of the mitochondrial calcium uniporter.Cardiac-enriched BAF chromatin-remodeling complex subunit Baf60c regulates gene expression programs essential for heart development and function.When signalling goes wrong: pathogenic variants in structural and signalling proteins causing cardiomyopathies.Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy.Hypertrophic cardiomyopathy: single gene disease or complex trait?
P2860
Q33844376-2235417E-B01E-4A5F-BE5A-2A8DF32901A8Q34675791-F258D724-9F85-49CA-8894-825C9CF48C3CQ35376847-B9F9C837-CBDF-4326-9ED0-52B77112674FQ35895661-AFB20520-0203-43E0-A8E5-BC2F35E259B3Q35914420-A9D6FB55-08F6-4C5D-8257-9AC48E80365AQ36272676-FFE4C114-C34A-49CD-8439-D08A9E921F51Q38872061-B9716FBD-7635-4407-A1B7-648ED9FDE4E9Q39050554-85DF9A44-451D-48C0-9610-D06C83201970Q39726366-E193F265-F15F-4002-A085-38D782F26DE3Q42515078-D6C36BB8-21BE-4398-83B7-94D6BEF2D36EQ42517468-37DB2501-8F34-41EE-ABA3-3EE10EBB02B3Q45976547-E59F61E1-C5CA-47D4-AFAB-F992E549BF39Q47104776-18D11780-C7E8-42DA-8747-BD657445D52FQ50083275-265BD6FF-38E3-4D6E-8410-9563C7B4A843Q51290025-47CC3AAC-71CE-4D00-9B74-5C65730AC848Q53463370-5535A617-6CD9-4A8F-A3C1-4A728D831733
P2860
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
@en
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
@nl
type
label
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
@en
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
@nl
prefLabel
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
@en
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.
@nl
P2093
P2860
P356
P1476
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy
@en
P2093
Andrea A Domenighetti
Anton Aboukhalil
Barbara McDonough
Christine E Seidman
Daniel S Herman
Danos C Christodoulou
David A Conner
David M McKean
Gyan Srivastava
Hiroko Wakimoto
P2860
P304
P356
10.1172/JCI70108
P407
P577
2014-02-10T00:00:00Z